Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011)

被引：69

作者：

Jones, Ronald N. ^{[1
]}

Sader, Helio S. ^{[1
]}

Mendes, Rodrigo E. ^{[1
]}

Flamm, Robert K. ^{[1
]}

机构：

[1] JMI Labs, N Liberty, IA 52317 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2013年 / 75卷 / 01期

关键词：

S; pneumoniae; Resistance; Ceftaroline; Vaccines;

D O I：

10.1016/j.diagmicrobio.2012.08.024

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

A 14-year longitudinal survey of Streptococcus pneumoniae (18,911) strains by the SENTRY Antimicrobial Surveillance Program shows significant increases in resistance to amoxicillin/clavulanate (18.9%), penicillin at a MIC of >= 4 mu g/mL (14.8%), and ceftriaxone (11.7%) among 2011 isolates. Fluoroquinolones (levofloxacin; 98.8% susceptible) and ceftaroline (99.1-100.0% susceptible depending on breakpoint criteria) exhibited high levels of potency, as did linezolid, tigecycline, and vancomycin (100.0%). In summary, resistance rates to several antimicrobials continue to rise after introductions of both pneumococcal conjugate vaccines, as noted from these results for 1998 through 2011. (C) 2013 Elsevier Inc. All rights reserved.

引用

页码：107 / 109

页数：3

共 50 条

[41] Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from Latin American patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998)
Lewis, MT
Gales, AC
Sader, HS
Pfaller, MA
Jones, RN
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 37 (01) : 63 - 74
[42] Bacterial pathogens isolated from patients with skin and soft tissue infections: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
Doern, GV
Jones, RN
Pfaller, MA
Kugler, KC
Beach, ML
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (01) : 65 - 72
[43] Prevalence and antimicrobial susceptibility profiles of leading nosocomial pneumonia pathogens: the ten-year report from the European SENTRY Antimicrobial Surveillance Program
Fritsche, T.
Sader, H.
Strabala, P.
Jones, R.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S180 - S181
[44] Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
Jones, RN
Croco, MAT
Kugler, KC
Pfaller, MA
Beach, ML
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 37 (02) : 115 - 125
[45] Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States -: A report from the College of American Pathologists Microbiology Proficiency Survey Program
Doern, GV
Brueggemann, AB
Pfaller, MA
Jones, RN
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1999, 123 (04) : 285 - 289
[46] Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States:: Results from the TRUST Surveillance Program, 1999-2000
Thornsberry, C
Sahm, DF
Kelly, LJ
Critchley, IA
Jones, ME
Evangelista, AT
Karlowsky, JA
CLINICAL INFECTIOUS DISEASES, 2002, 34 : S4 - S16
[47] Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000
Mutnick, AH
Biedenbach, DJ
Turnidge, JD
Jones, RN
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (01) : 65 - 73
[48] Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019
Pfaller, Michael A.
Huband, Michael D.
Shortridge, Dee
Flamm, Robert K.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 : 337 - 351
[49] Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003)
Fedler, Kelley A.
Jones, Ronald N.
Sader, Hello S.
Fritsche, Thomas R.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 55 (02) : 157 - 164
[50] Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from the SENTRY Antimicrobial Surveillance Program (1997-99)
Jones, RN
Pfaller, MA
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 39 (04) : 237 - 243

← 1 2 3 4 5 →